EcoDrugPlus

Phosphodiesterase 3a

Ensembl ID : ENSSTUG00000001994
Gene Symbol: PDE3A
3 Cross references
209 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSSTUG00000048887
Gene Symbol: PDE3A
3 Cross references
207 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSSTUG00000021598
Gene Symbol: PDE3B
3 Cross references
211 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSSTUG00000021726
Gene Symbol: PDE3B
3 Cross references
211 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSSTUG00000015806
Gene Symbol: PDE4A
3 Cross references
193 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSSTUG00000006652
Gene Symbol: PDE4A
3 Cross references
192 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSSTUG00000037779
Gene Symbol: PDE4B
3 Cross references
218 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSSTUG00000041543
Gene Symbol: PDE4B
3 Cross references
219 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSSTUG00000047018
Gene Symbol: PDE4B
3 Cross references
219 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSSTUG00000014883
Gene Symbol: PDE4B
3 Cross references
218 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSSTUG00000009874
Gene Symbol: PDE4D
3 Cross references
213 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSSTUG00000005450
Gene Symbol: PDE4D
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).